lactic acid has been researched along with Infectious Diseases in 9 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the prognostic value of the albumin-to-fibrinogen ratio (AFR) in patients with sepsis as a consequence of infection at various sites." | 8.12 | Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites. ( Chang, B; Li, S; Shen, Y; Wang, N, 2022) |
| "This study investigated the prognostic value of the albumin-to-fibrinogen ratio (AFR) in patients with sepsis as a consequence of infection at various sites." | 4.12 | Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites. ( Chang, B; Li, S; Shen, Y; Wang, N, 2022) |
| "Many global infectious diseases are not well-controlled, underlining a critical need for new, more effective therapies." | 1.51 | Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells. ( Choi, SYC; Gout, PW; Killam, J; Liu, R; Wang, Y; Wong, J; Xu, E, 2019) |
| "Our primary outcome was critical illness, defined as one or more of the composite outcomes of death, vasopressor use or intensive care unit (ICU) admission within 72 hours of presentation." | 1.48 | Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness. ( Baumann, BM; Darger, B; Fernandez, D; Greenwood, JC; Jung, SY; Kilgannon, JH; Nuckton, TJ; Rodriguez, RM; Shofer, FS; Speich, KG; Troeger, D; Valencia, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, SY | 1 |
| Ryu, S | 1 |
| Oh, SK | 1 |
| Park, JS | 1 |
| You, YH | 1 |
| Jeong, WJ | 1 |
| Cho, YC | 1 |
| Ahn, HJ | 1 |
| Kang, CS | 1 |
| Li, S | 1 |
| Shen, Y | 1 |
| Chang, B | 1 |
| Wang, N | 1 |
| Rodriguez, RM | 1 |
| Greenwood, JC | 1 |
| Nuckton, TJ | 1 |
| Darger, B | 1 |
| Shofer, FS | 1 |
| Troeger, D | 1 |
| Jung, SY | 1 |
| Speich, KG | 1 |
| Valencia, J | 1 |
| Kilgannon, JH | 1 |
| Fernandez, D | 1 |
| Baumann, BM | 1 |
| Wong, J | 1 |
| Choi, SYC | 1 |
| Liu, R | 1 |
| Xu, E | 1 |
| Killam, J | 1 |
| Gout, PW | 1 |
| Wang, Y | 1 |
| MECL, A | 3 |
| PETERA, V | 3 |
| LAHN, V | 3 |
| KUBICEK, J | 2 |
| ZAWISZA-ZENKTELER, W | 1 |
| Bongaerts, GP | 1 |
| van den Heuvel, LP | 1 |
9 other studies available for lactic acid and Infectious Diseases
| Article | Year |
|---|---|
Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care.
Topics: Aged; Aged, 80 and over; Albumins; APACHE; Blood Urea Nitrogen; C-Reactive Protein; Communicable Dis | 2021 |
Prognostic Value of Albumin-to-Fibrinogen Ratio for 28-Day Mortality among Patients with Sepsis from Various Infection Sites.
Topics: Albumins; Communicable Diseases; Fibrinogen; Humans; Lactic Acid; Prognosis; Retrospective Studies; | 2022 |
Comparison of qSOFA with current emergency department tools for screening of patients with sepsis for critical illness.
Topics: Adult; Aged; Area Under Curve; Biomarkers; Cohort Studies; Communicable Diseases; Critical Illness; | 2018 |
Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.
Topics: Aerobiosis; Antimetabolites; Communicable Diseases; Glycolysis; Immune Evasion; Lactic Acid | 2019 |
The influence of physical work upon the lactic acid level in infective hepatitis.
Topics: Communicable Diseases; Hepatitis; Hepatitis A; Lactic Acid; Work | 1954 |
[Method od determination of working capacity in infectious hepatitis; effect of work on lactic acid in the blood and on certain respiratory functions].
Topics: Communicable Diseases; Hepatitis; Hepatitis A; Humans; Lactic Acid; Work | 1954 |
[Studies on a method of determination of working capacity in infectious hepatitis; clinical use of blood lactic acid and of certain respiratory functions following work load in evaluation of convalescence following infectious hepatitis].
Topics: Breath Tests; Communicable Diseases; Convalescence; Hepatitis; Hepatitis A; Humans; Lactic Acid; Res | 1957 |
GLYCOGEN AND LACTIC ACID IN RABBIT'S PERIPHERAL BLOOD IN THE COURSE OF ACUTE STAPHYLOCOCCUS INFECTION.
Topics: Animals; Blood; Communicable Diseases; Glycogen; Lactates; Lactic Acid; Lagomorpha; Rabbits; Researc | 1965 |
Microbial proteinase inside human cells as anti-mitochondrial activity: a new virulence factor in infectious diseases?
Topics: Biological Transport; Carrier Proteins; Communicable Diseases; Endopeptidases; Humans; Hydrolases; I | 2008 |